Diabetes Diagnostics: Market Research Report

January 2019 | 381 pages | ID: DBD21F18BE6EN
Global Industry Analysts, Inc

Abstracts

This report analyzes the worldwide markets for Diabetes Diagnostics in US$ by the following Product Segments: Continuous Glucose Monitoring (CGM) Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

Company profiles are primarily based on public domain information including company URLs. The report profiles 58 companies including many key and niche players such as -

• A.Menarini Diagnostics Ltd.
• Abbott Diabetes Care, Inc.
• Acon Laboratories, Inc.
• AgaMatrix, Inc.
• Apex Biotechnology Corporation
• ARKRAY, Inc.

Contents

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Continuous Glucose Monitoring (CGM) Systems
HbA1c Testing Devices
Blood Glucose Monitoring Devices

2. INDUSTRY OVERVIEW

Diabetes Diagnostics: Towards Easier, Economic, and Efficient Management of the Global Diabetes Epidemic
Evolution of Diabetes Testing over the Years with Key Features in Each Period
Growth Drivers in a Nutshell
Alarming Levels of Diabetes Incidence Worldwide Drives Demand for Diabetes Diagnostic Devices

Table 1. Worldwide Prevalence of Diabetes: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045 (includes corresponding Graph/Chart)

Table 2. Global Prevalence (%) of Diabetes in Adults (20-79) by Region for the Years 2017 and 2045 (includes corresponding Graph/Chart)

Table 3. Global Prevalence of Diabetes - Number of Adults Diagnosed with Diabetes (in Million) by Gender for the Year 2017 (includes corresponding Graph/Chart)

Table 4. Worldwide Diabetes Prevalence (%) in Adults by Age Group and Gender for the Year 2017 (includes corresponding Graph/Chart)

Table 5. Diabetes Prevalence in Rural and Urban Areas - Number of Adults with Diagnosed Diabetes (in Million) in Urban and Rural Areas for 2017 and 2045 (includes corresponding Graph/Chart)

Table 6. Top 10 Countries with Highest Number of Adults Diagnosed with Diabetes (in Million) for 2017 and 2045 (includes corresponding Graph/Chart)

Diabetes Emerges as One of the Leading Causes of Death

Table 7. Proportion of Deaths on Account of Diabetes in People Aged Less than 60 Years by Region for the Year 2017 (includes corresponding Graph/Chart)

Etiological Factors Causing Diabetes
Future Prospects Remain Favorable for Diabetes Diagnostics Market
Developed Regions Remain Primary Revenue Contributors

Table 8. Developed Regions Account for nearly 4/5th Share of World Diabetes Diagnostics Market: Percentage Breakdown of Value Sales for Developed and Developing Regions (2018E & 2022P) (includes corresponding Graph/Chart)

Developing Countries Continue to Offer Significant Growth Opportunities

Table 9. Global Diabetes Diagnostics Market - Geographic Regions Ranked by CAGR (Value) for 2015-2022: Asia-Pacific (excluding Japan), Latin America, Europe, US, Rest of World, Canada, and Japan (includes corresponding Graph/Chart)

Key Factors Driving Sales of Diabetes Diagnostics in Developing Regions
Steep Increase in Number of Hospitals & Diagnostics Centers
Growing Healthcare Awareness & Parallel Increase in Consumer Healthcare Spending
Stable Economic Scenario to Underpin Market Expansion

Table 10. World Real GDP Growth Rates in % (2016-2019P): Breakdown by Country/Region (includes corresponding Graph/Chart)

3. MARKET TRENDS, DRIVERS & ISSUES

Growing Prominence of Real-Time Glucose Sensing and Monitoring Drive Robust Demand for Minimally-Invasive CGM Devices
CGM Market Gradually Breaks through Barriers to Adoption

Table 11. Penetration Rate (%) of CGM Devices in Type 1 and Type 2 Diabetes Market in the United States: 2013 through 2020 (includes corresponding Graph/Chart)

Intensive Care Units: A Highly Promising Market for CGMs
Proven Efficacy for Development of Intervention Strategies Drives Demand for HbA1c Testing Devices
Rising Popularity of Near Patient Testing Benefits Prospects for HbA1c Devices
Myriad Benefits of POC HbA1c Tests over Lab Tests Drives Widespread Adoption
Home HbA1c Testing: An Overview
Glycated Albumin: A Potential Threat to HbA1c?
Approval for HbA1c Testing for Diabetes Diagnosis: An Opportunity to Tap
Is HbA1c Test Right in Being Recommended for Diagnostic Purposes?
HbA1c Tests for Diabetes Diagnosis Need to Address Issues Related to Hemoglobin Variants
ESC and ADA Release Revised Guidelines for HbA1c Testing
Despite Competition from CGM Systems and HbA1c Testing Devices, BGM Devices Continues to Dominate Sales
Cost: The Ultimate Factor Favoring Growth in Demand for Blood Glucose Monitoring Systems
Self-Monitoring/Household Blood Glucose: Sustaining Growth in Demand
Key Trends in the Glucose Meter/Monitoring Systems
Smartphone Penetration Favors SMBG Market

Table 12. Global Market for Smartphones: Volume Sales in Million Units for 2011, 2013, 2015 & 2018E (includes corresponding Graph/Chart)

Table 13. Smartphone Penetration as a Proportion (%) of Total Mobile Users in Select Countries (2017) (includes corresponding Graph/Chart)

Demand for BGM Products to Witness Varying Patterns in Developed and Developing Markets
Barriers to Adoption of New Technology in BGM Products
Accuracy Issues Plague Blood Glucose Meters Market
Advancements in Glucose Monitoring Devices Offers a New Ray of Hope
Undiagnosed Diabetes: A Major Healthcare Challenge Offering Huge Untapped Potential

Table 14. Proportion of Undiagnosed Diabetes Cases (20-79 Years) by Region for the Year 2017 (includes corresponding Graph/Chart)

Undiagnosed Diabetics: More Prone to Cardiovascular Diseases
Increased Vulnerability of Diabetics to Various Health Complications Boosts Demand for Diagnostic Devices
Heart Disease
Stroke
High Blood Pressure
Blindness
Kidney Disease
Nerve Disease
Amputations
Dental Disease
Pregnancy
Microvascular Complications (Small Blood Vessel Damage)
Retinopathy
Diabetic Neuropathy
Nephropathy
Macrovascular Complications (Large Blood Vessel Damage)
Cardiac Problems
Hypertension (High Blood Pressure)
Infections
Impotence
Pregnancy Complications
Other Complications Resulting from Diabetes
Obesity
Obsessive Compulsive Disorder
Foot Ulcers
Dementia
Hypoglycemia
Diabetic Ketoacidosis
Non-Insulin-Dependent Diabetes Mellitus (NIDDM) Lead to Cardiovascular Complications
High Risk of Diabetes in the Fast Expanding Aging Population Benefit Market Expansion
Demographic Statistics of the Global Aging Populace: Unfurling the Market Potential

Table 15. Global Aging Population (in Thousands) by Age Group: 1975-2050 (includes corresponding Graph/Chart)

Table 16. Global Population by Age-Group: Percentage Change Over the Period 2010-2050 (includes corresponding Graph/Chart)

Table 17. Global Aging Population in Select Regions/Countries: Population of 60+ Individuals in ‘000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart)

Glycosylated Hemoglobin Tests Pave the Way for Early-Stage Diabetes Diagnosis
Increasing Healthcare Expenditure Aids Diabetes Diagnostics & Testing Market

Table 18. Healthcare Spending as % of GDP by Geographic Region (2016) (includes corresponding Graph/Chart)

Table 19. Per Capita Healthcare Spending (in $) in Select Developed Countries for the Year 2016 (includes corresponding Graph/Chart)

Rising Expenditure on Diabetes Care Drives Diagnostic Devices Sales

Table 20. Healthcare Spending (in US$ Billion) by People with Diabetes (20-79 Years) for the Years 2011, 2013, 2015 and 2017 (includes corresponding Graph/Chart)

Table 21. Health Spending (In US$ Billion) due to Diabetes in Adults (20-79 years) - Breakdown by Region for the Years 2017 and 2045 (includes corresponding Graph/Chart)

Table 22. Leading Countries by Health Expenditure on Diabetes by Adults for the Year 2017 (includes corresponding Graph/Chart)

Table 23. Expenditure on Diabetes in Adults (20-79) as % of Total Healthcare Spending by Region (2017) (includes corresponding Graph/Chart)

Table 24. Health Expenditure on Diabetes: Average Diabetes-Related Spending per Person with Diabetes in US$ by Region for 2017 (includes corresponding Graph/Chart)

Table 25. Health Expenditure on Diabetes: Top Countries Ranked by Diabetes-Related Spending per Person with Diabetes (in US$) for 2017 (includes corresponding Graph/Chart)

Increasing Obesity Levels Underpins Market Growth

Table 26. Global Obesity Epidemic: Percentage of Overweight, Obese, and Severely Obese Adults for 2014 & 2025 (includes corresponding Graph/Chart)

Table 27. Severely Obese Population (in Thousands) Worldwide by Country: 2014 & 2025 (includes corresponding Graph/Chart)

4. PRODUCT OVERVIEW

A Prelude
Continuous Glucose Monitoring (CGM) Systems
Hemoglobin A1c (HbA1c) Test
HbA1c Test Types
HbA1c Laboratory Testing
Analytical Techniques Used for Quantifying HbA1c in Labs
Standardization of HbA1c Results

Table 28. CAP Accuracy Grading for HbA1c Measurements (2007-2013)

HbA1c Point of Care Testing & Self-Monitoring
Blood Glucose Testing Devices
Blood Glucose Monitor/Meter
Diabetes Testing Supplies
Blood Glucose Test Strips
Lancet
Lancet Device
Reagent Strips
Reagent Tablet
Diabetes: A Chronic Body Disorder
Diabetes Symptoms
Types of Diabetes
Type I Diabetes: Insulin-Dependent Diabetes Mellitus (IDDM)
Type II Diabetes: Non Insulin-Dependent Diabetes Mellitus (NIDDM)

5. COMPETITIVE LANDSCAPE

Major Pharma Players Dominate Diabetes Diagnostics Market
Competition with Local Pharma Companies Intensifies in Regional Markets
Continuous Glucose Monitoring Systems (CGMS) Market

Table 29. Leading Players in the Global Continuous Glucose Monitoring Market (2017): Percentage Breakdown of Value Sales for Abbott, DexCom, Medtronic and Others (includes corresponding Graph/Chart)

Medtronic Dominates the Global CGM Devices Market
Leading Companies Continue to Focus on CGM Innovations
Leading Companies and their CGM Innovations
Blood Glucose Monitoring (BGM) Devices Market

Table 30. Leading Players in the Global Blood Glucose Monitoring Devices Market (2017): Percentage Breakdown of Value Sales for Abbott, LifeScan (J&J), Roche, and Others (includes corresponding Graph/Chart)

Quality Products at Low Prices: Mantra for Success in the Marketplace
After PDAs, SMBG Makers Turn to Mobile Devices to Woo Users on the Move
Competition in the HbA1c Testing Devices Market

Table 31. Leading Players in the Global HbA1c Reagent Market (2017): Percentage Breakdown of Value Sales for Siemens Healthineers and Others (includes corresponding Graph/Chart)

Select Laboratory-based HbA1c Testing Products/Analyzers
Select Point of Care HbA1c Testing Products/ Analyzers
Major POC HbA1c Tests in the Market
Select HbA1c POC Tests in the Market - A Comparison
Product Innovation is the Name of the Game for HbA1c Testing Device Companies
Manufacturers Focus on Offering Products for Developing Markets
Innovations & Product Advancements: Prime Focus Area for Vendors
mHealth Solutions for Diabetes Diagnosis
Non-invasive Wearable Glucose Testing Devices
Apple and Google to Develop Wearable Continuous Glucose Monitors
GlySens Focus on Developing Implantable Continuous Glucose Monitor
Researchers Develop Prototype of Wearable Closed-Loop System
Glucovation SugarSenz: Cloud Enabled CGM Device
EyeSense to Develop Affordable CGM Device
Insulin Pump with CGM Sensor
Glucose Monitoring through Smartphone Apps: The Latest Breakthrough

Table 32. No. of Diabetic Patients Worldwide and No. of App-Using Patients (in Million): 2014 & 2018P (includes corresponding Graph/Chart)

Bar-Illan University of Israel’s Research for Non-invasive, Wearable Glucose Testing Device
Nanotechnology-based Breathalyzer for Non-Invasive Glucose Monitoring
EMG 1000: Needle-free Device for Glucose Monitoring
Glucase: Smartphone Case with Glucose Testing Kit
Painless Diabetes Monitoring Using NFC Technology
GlucoSense: Laser Device for Non-invasive Monitoring of Glucose Levels
ClearPath DS-120: Enabling Early Detection of Diabetes & Prediabetes
Sugar. IQ App: Powerful Features for Diabetics
NoStrip Technology: Eliminating Need for Individual Test Strips
Artificial Pancreas System (APS): The Future of Diabetes Care
5.1 Focus on Select Global Players
A. Menarini Diagnostics Ltd. (UK)
Abbott Diabetes Care, Inc. (USA)
Acon Laboratories, Inc. (USA)
AgaMatrix, Inc. (USA)
Apex Biotechnology Corporation (Taiwan)
ARKRAY, Inc. (Japan)
Ascensia Diabetes Care Holdings AG (Switzerland)
B. Braun Melsungen AG (Germany)
Becton, Dickinson and Company (USA)
BIONIME Corporation (Taiwan)
Bio-Rad Laboratories, Inc. (USA)
Danaher Corporation (USA)
Beckman Coulter, Inc. (USA)
HemoCue AB (Sweden)
DexCom, Inc. (USA)
Diazyme Laboratories Inc. (USA)
EKF Diagnostics Holdings Plc (UK)
LifeScan, Inc. (USA)
Medtronic PLC (Ireland)
Nova Biomedical Corporation (USA)
OSANG Healthcare Co., Ltd. (South Korea)
Roche Diabetes Care, Inc. (USA)
Sanofi S. A. (France)
Sanwa Kagaku Kenkyusho Co, Ltd. (Japan)
Siemens Healthineers (Germany)
Sinocare, Inc. (China)
PTS Diagnostics (USA)
Trividia Health, Inc. (USA)
TaiDoc Technology Corporation (Taiwan)
Tandem Diabetes Care, Inc. (USA)
Terumo Corporation (Japan)
Tosoh Bioscience, Inc. (USA)
Trinity Biotech plc (Ireland)
Ypsomed AG (Switzerland)
5.2 Product Launches/Approvals
Medtronic Receives CE Mark for MiniMed 670G Hybrid Closed Loop System
Medtronic and IBM Watson Health Launch Sugar. IQ Smart Diabetes Assistant
Nova Biomedical Bags USFDA Approval for StatStrip Glucose Hospital Meter in Critically Ill Patient Care
Medtronic Bags USFDA Approval for New Arm Indication for Guardian Sensor 3 CGM System
Tandem Diabetes Care Bags CE Mark Approval for t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM Integration
DexCom Receives CE Mark for DexCom G6 System
DexCom Receives US FDA Marketing Approval for Dexcom G6 CGM System
Abbott Introduces Afinion 2 Analyser in the US
Roche Diabetes Care Launches Accu-Chek Instant S Glucometer in India
Senseonics Launches Remote Monitoring Feature for Eversense CGM Systems in EMEA
DarioHealth Launches Retail Sales of Dario BGM System on Amazon Prime
Senseonics Receives CE Mark Approval for Eversense XL CGM System
Abbott Bags US FDA Approval for FreeStyle Libre as a Replacement for BGM
ARKRAY Introduces New Aluminum Foil Packaged BG Sensor for PocketChem BG PG-7320
U. S. ARKRAY Launches ADAMS A1c HA-8180V System for Hemoglobin A1c Testing
ARKRAY Releases ADAMS A1c HA-8190V Glycohemoglobin Analyzer
Bionime Launches GM700SB Bluetooth Glucose Meter in Taiwan
Abbott Bags Health Canada License for FreeStyle Libre Flash Glucose Monitoring System
Medtronic Unveils MiniMed 670G Hybrid Closed Loop Insulin Delivery System
HemoCue Launches HemoCue HbA1c 501 System in Thailand
Roche Introduces Accu-Chek Guide System and SimplePay Savings Program
One Drop Launches iOS-compatible One Drop Chrome BGM Kit
5.3 Recent Industry Activity
PTS Diagnostics to Move World Headquarters to Whitestown from Indianapolis
Siemens Healthineers Inks Comarketing Agreement with Hill-Rom
Tandem Inks Distribution Deals in Australia and New Zealand
Senseonics Inks Development Agreement with Beta Bionics
DexCom Inks Distribution Deal with Terumo in Japan
Innovation Zed Teams Up with GlucoRx
Tandem Diabetes Care Inks Distribution Agreement with Movi SpA in Italy
Platinum Equity to Acquire LifeScan
Tandem Submits License Application to Health Canada for t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM Integration
Tandem Diabetes Care Inks Distribution Deal with Rubin Medical
Ascensia Diabetes Care Expands Scope of Strategic Alliance with Insulet
Tandem Diabetes Care Commences Full-Scale Operations at Newly Launched San Diego Facility
Infopia Becomes OSANG Healthcare
DexCom Collaborates with Eli Lilly and Company
Animas to Discontinue Animas Vibe and OneTouch Ping Insulin Pumps Business
Abbott Acquires Alere
Fitbit Teams Up with Dexcom for Diabetes Care
Roche and Accenture to Develop Core Data Platform for Digital Diabetes Ecosystem
Radisens Raises Additional Funding to Commercialize its Diabetes Management Platform
Abbott Teams Up with Bigfoot Biomedical
Ascensia Diabetes Care Joins Hands with DexCom
Roche to Acquire mySugr
Roche Inks Exclusive Partnership Deal with Medtronic
Asensia Diabetes Care Inks Global Technology Partnership Deal with Glooko

6. GLOBAL MARKET PERSPECTIVE

Table 33. World Recent Past, Current & Future Analysis for Diabetes Diagnostics by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 34. World Historic Review for Diabetes Diagnostics by Geographic Region/ Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 35. World 14-Year Perspective for Diabetes Diagnostics by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

By Product Segment:

Table 36. World Recent Past, Current & Future Analysis for CGM Systems by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 37. World Historic Review for CGM Systems by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 38. World 14-Year Perspective for CGM Systems by Geographic Region/ Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

Table 39. World Recent Past, Current & Future Analysis for HbA1c Testing Devices by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 40. World Historic Review for HbA1c Testing Devices by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 41. World 14-Year Perspective for HbA1c Testing Devices by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

Table 42. World Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 43. World Historic Review for Blood Glucose Monitoring Devices by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 44. World 14-Year Perspective for Blood Glucose Monitoring Devices by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

7. REGIONAL MARKET PERSPECTIVE

7.1 The United States
A. Market Analysis
The United States: Largest Market for Diabetes Diagnostics

Table 45. US Accounts for about 2/5th Share of the World Diabetes Diagnostics Market: Percentage Breakdown of Value Sales for US and Rest of World (2018E & 2022P) (includes corresponding Graph/Chart)

Diabetes: A Leading Cause of Death in the US & North America

Table 46. Diabetes and Population Statistics in North America and Caribbean Region (2017 & 2045) (includes corresponding Graph/Chart)

Table 47. Diabetes Statistics in the US (2017) - Number of Adults with Diabetes (20-79) (in 000s), Diabetes age-adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed Diabetes (‘000s), and Number of Diabetes-Related Deaths (in ‘000s)

Prevalence Varies by Race/Ethnicity

Table 48. Diabetes Prevalence Rate (%) in the US - Breakdown by Ethnicity/Race for the Year 2020 (includes corresponding Graph/Chart)

Table 49. Diabetes Prevalence in the US (2015): Percentage Share of Number of Diabetics by Gender (includes corresponding Graph/Chart)

Aging Population: A Key Growth Factor

Table 50. Diabetes Prevalence in the US (2015): Percentage Share of Number of Diabetics by Age Group (includes corresponding Graph/Chart)

Table 51. Aging Population in the US (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)

Table 52. North American Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)

Economic Burden of Diabetes

Table 53. Total Healthcare Expenditure (in US$ Billion) and Average Healthcare Expenditure Per Person (in US$) on Diabetes among Adults (20-79 years) in the US for 2017

Table 54. Health Expenditure (in US$ Billion) on Diabetes in North America: 2017 & 2045 (includes corresponding Graph/Chart)

Healthcare Reform Legislation: Impact on Diabetes Diagnostics
HbA1c Testing for Diabetes Detection Gains Support
ADA Recommends HbA1c Test for Diabetes Diagnosis
ADA Recommends New Guidelines for HbA1c Testing for Certain Patients
HbA1c – Increasingly Moving into Physician’s Office
Growing Inclination towards CLIA-Waived Tests
Study Finds Dentist Visits to be an Opportunity for HbA1c-based Diabetes Screening & Management
Wearable and Non-Invasive Glucose Monitoring Devices Favored
FDA Guidance for Blood Glucose Meters
Emerging 'Grey Market' for Testing Strips
Competitive Scenario
US Near Patient HbA1c Testing: A Highly Consolidated Market

Table 55. Leading Players in the US Near Patient HbA1c Testing Market (2017): Percentage Breakdown of Revenues for Abbott, Siemens Healthineers and Others (includes corresponding Graph/Chart)

CGM Devices: Highly Consolidated Marketplace

Table 56. Leading Companies in the US CGM Market (2014 & 2020P): Percentage Share Breakdown of Revenue for Abbott, DexCom, and Medtronic (includes corresponding Graph/Chart)

Companies Focus on Research for Better Diabetes Diagnostics
Drugstores Benefit from the Diabetic Care Category
Integrated Products: An Upcoming Trend
B. Market Analytics

Table 57. US Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 58. US Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 59. US 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

7.2 Canada
A. Market Analysis
Diabetes Statistics in Canada: Opportunity Indicator for Diabetes Diagnostics

Table 60. Diabetes Statistics in Canada (2017) - Number of Adults with Diabetes (20-79) (in 000s), Diabetes age-adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed Diabetes (‘000s), and Number of Diabetes-Related Deaths (in ‘000s)

Table 61. Adult Diabetes in Canada (2017E): Percentage Share Breakdown of Diabetic Population by Gender (includes corresponding Graph/Chart)

Table 62. Adult Diabetes in Canada (2017E): Percentage Share Breakdown of Diabetic Population by Age Group (includes corresponding Graph/Chart)

Aging Population: Key Opportunity Indicator

Table 63. Aging Population in Canada (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)

B. Market Analytics

Table 64. Canadian Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 65. Canadian Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 66. Canadian 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

7.3 Japan
A. Market Analysis
Growing Aging Population Drives Diabetes Diagnostics Market

Table 67. Aging Population in Japan (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)

Trends Influencing Diabetes Diagnostics Market

Table 68. Diabetes Statistics in Japan (2017) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in ‘000s), Diabetes age-adjusted (20-79) Comparative Prevalence (%), and Number of Diabetes-Related Deaths (in ‘000s)

B. Market Analytics

Table 69. Japanese Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 70. Japanese Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 71. Japanese 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

7.4 Europe
A. Market Analysis
Diabetes Diagnostics Market in Europe – A Promising Outlook
Growing Uptake of HbA1c Tests Bodes Well
Proven Efficacy and Benefits of POCT HbA1C Tests Spur Adoption
Diabetes Statistics in Europe

Table 72. Diabetes and Population Statistics in Europe (2017 & 2045) (includes corresponding Graph/Chart)

Table 73. Diabetes Statistics in Europe (2017) - Adults with Diabetes (20-79) in 1,000s, Diabetes Age-Adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed Diabetes (20-79) in 1,000s, and Diabetes Related Deaths (20-79 years) for Select Countries (includes corresponding Graph/Chart)

Reimbursement Scenario
B. Market Analytics

Table 74. European Recent Past, Current & Future Analysis for Diabetes Diagnostics by Geographic Region/Country - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 75. European Historic Review for Diabetes Diagnostics by Geographic Region/ Country - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 76. European 14-Year Perspective for Diabetes Diagnostics by Geographic Region/ Country - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

Table 77. European Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 78. European Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 79. European 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

  7.4.1 France
A. Market Analysis
France: Diabetes & Aging Statistics

Table 80. Diabetes Statistics in France (2017) - Adults with Diabetes (20-79) in 1,000s, Diabetes Age-Adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed Diabetes (20-79) in 1,000s, and Diabetes Related Deaths (20-79 years)

Table 81. Aging Population in France (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)

B. Market Analytics

Table 82. French Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 83. French Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 84. French 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

  7.4.2 Germany
A. Market Analysis
Germany: Diabetes & Aging Statistics

Table 85. Diabetes Statistics in Germany (2017) - Adults with Diabetes (20-79) in 1,000s, Diabetes Age-Adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed Diabetes (20-79) in 1,000s, and Diabetes Related Deaths (20-79 years)

Table 86. Aging Population in Germany (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)

B. Market Analytics

Table 87. German Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 88. German Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 89. German 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

  7.4.3 Italy
A. Market Analysis
Italy: Diabetes & Aging Statistics

Table 90. Diabetes Statistics in Italy (2017) - Adults with Diabetes (20-79) in 1,000s, Diabetes Age-Adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed Diabetes (20-79) in 1,000s, and Diabetes Related Deaths (20-79 years)

Table 91. Aging Population in Italy (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)

B. Market Analytics

Table 92. Italian Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 93. Italian Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 94. Italian 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

  7.4.4 The United Kingdom
A. Market Analysis
Self-Monitoring Blood Glucose Meters Gain Popularity
NHS England Launches Action for Diabetes Plan
NHS Guidelines for Lancets, Testing Strips, and Meters for Blood Glucose Testing
NICE Recommendations for Self-Monitoring Blood Glucose (SMBG)
Diabetes Statistics & Management – An Insight

Table 95. Diabetes Statistics in United Kingdom (2017) - Adults with Diabetes (20-79) in 1,000s, Diabetes Age-Adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed Diabetes (20-79) in 1,000s, and Diabetes Related Deaths (20-79 years) for Select Countries

Table 96. Aging Population in the United Kingdom (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)

Rising Obesity Cases – Increased Risk of Diabetes
Type 1 Diabetes in Children

Table 97. Number of Children with Type 1 Diabetes in Select Countries (2015) (includes corresponding Graph/Chart)

B. Market Analytics

Table 98. UK Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 99. UK Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 100. UK 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

  7.4.5 Spain
A. Market Analysis
Spain: Diabetes & Aging Statistics

Table 101. Diabetes Statistics in Spain (2017) - Adults with Diabetes (20-79) in 1,000s, Diabetes Age-Adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed Diabetes (20-79) in 1,000s, and Diabetes Related Deaths (20-79 years)

Table 102. Aging Population in Spain (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)

B. Market Analytics

Table 103. Spanish Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 104. Spanish Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 105. Spanish 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

  7.4.6 Russia
A. Market Analysis
Russia: Diabetes & Aging Statistics

Table 106. Diabetes Statistics in Russian Federation (2017) - Adults with Diabetes (20-79) in 1,000s, Diabetes Age-Adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed Diabetes (20-79) in 1,000s, and Diabetes Related Deaths (20-79 years)

Table 107. Aging Population in Russia (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)

B. Market Analytics

Table 108. Russian Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 109. Russian Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 110. Russian 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

  7.4.7 Rest of Europe
Market Analysis

Table 111. Rest of European Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 112. Rest of European Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 113. Rest of European 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

7.5 Asia-Pacific
A. Market Analysis
Asia-Pacific: A Market Laden with Opportunities

Table 114. China and India Propel Asia-Pacific’s Share in the World Diabetes Diagnostics Market - Geographic Regions Ranked by CAGR (Value) for 2015-2022: China, India, Germany, UK, US, France, Italy, Russia, Spain, Canada, and Japan (includes corresponding Graph/Chart)

Rising Diabetes Incidence Offers Significant Growth Opportunities

Table 115. Diabetes and Population Statistics in Western Pacific (2017 & 2045) (includes corresponding Graph/Chart)

Table 116. Diabetes Statistics in Western Pacific (2017) - Number of Adults with Diabetes (20-79) (in 000s), Diabetes age-adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed diabetes ('000s) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart)

Table 117. Diabetes and Population Statistics in South East Asia (2017 & 2045) (includes corresponding Graph/Chart)

Table 118. Diabetes Statistics in South East Asia (2017) - Number of Adults with Diabetes (20-79) (in 000s), Diabetes age-adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed Diabetes ('000s) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart)

Public and Private Sector Diabetes Care
Public Sector
Private Sector
Role of Healthcare Societies and Associations
India
Bangladesh
Western Pacific Declaration on Diabetes
Technological Integration: An Emerging Trend in the Asia-Pacific Medical Devices Market
BGM Devices: Competitive Landscape
An Overview of Key Regional Markets
China
China: Lower Penetration Offers High Growth Potential

Table 119. Leading Companies in the Chinese Glucose Meters Market (2017): Percentage Share Breakdown of Revenues for Abbott, J&J, Roche, Sinocare and Others (includes corresponding Graph/Chart)

Reimbursement of Diabetes Diagnostics in China (2015): Glucose Meters and Test Strips’ Reimbursement Status and Percentage
Increasing Diabetes Incidence Remains Growth Driver

Table 120. Diabetes Statistics in China (2017) - Number of Adults with Diabetes (in 000s), Diabetes age-adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed Diabetes (in ‘000s), and Number of Diabetes-Related Deaths (in ‘000s)

Key Opportunity Indicator: Aging Population

Table 121. Aging Population in China (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)

India
Rising Diabetic Populace Spurs Growth in the Indian Market
Blood Glucose Monitoring Market: An Overview
Growth Stimulants & Challenges in a Nutshell
HbA1c Testing on Growth Spree
Most Glucose Meters in Indian Market Feature Imported Technology
ICMR Develops New Indigenous, Low-Cost Diabetes Detection Technology
Market Restraints
Rising Diabetes Cases – Opportunities for Diabetes Diagnostics

Table 122. Diabetes Statistics in India (2017) - Number of Adults with Diabetes (in 000s), Diabetes age-adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed Diabetes (in ‘000s), and Number of Diabetes-Related Deaths (in ‘000s)

Key Opportunity Indicator: Aging Population

Table 123. Aging Population in India (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)

Australia
Australia: An Insight into Diabetes Statistics

Table 124. Diabetes Population in Australia (2017): Percentage Breakdown of Number of Individuals with Diabetes by Age Group (includes corresponding Graph/Chart)

Table 125. Diabetes Statistics in Australia (2017) - Number of Adults with Diabetes (in 000s), Diabetes age-adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed Diabetes (in ‘000s), and Number of Diabetes-Related Deaths (in ‘000s)

Key Opportunity Indicator: Aging Population Statistics in Rest of Asia-Pacific

Table 126. Aging Population in Rest of Asia by Country (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)

B. Market Analytics

Table 127. Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Diagnostics by Geographic Region/Country - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 128. Asia-Pacific Historic Review for Diabetes Diagnostics by Geographic Region/ Country - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 129. Asia-Pacific 14-Year Perspective for Diabetes Diagnostics by Geographic Region/Country - Percentage Breakdown of Dollar Sales for China, India, and Rest of Asia-Pacific Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

Table 130. Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 131. Asia-Pacific Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 132. Asia-Pacific 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

7.6 Latin America
A. Market Analysis
Diabetes in Latin America – A Glance at Key Statistics

Table 133. Diabetes and Population Statistics in South & Central America (2017 & 2045) (includes corresponding Graph/Chart)

Table 134. Diabetes Statistics in South & Central America (2017) - Number of Adults with Diabetes (20-79 (in 000s), Diabetes age-adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed Diabetes) ('000s), and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart)

Key Opportunity Indicator: Aging Population

Table 135. Aging Population in Latin America and the Caribbean by Region (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)

Table 136. Aging Population in Latin America by Country (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)

B. Market Analytics

Table 137. Latin American Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 138. Latin American Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 139. Latin American 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

7.7 Rest of World
A. Market Analysis
Diabetes Statistics in Africa and the Middle East

Table 140. African Diabetes and Population Statistics (2017 & 2045) (includes corresponding Graph/Chart)

Table 141. Diabetes Statistics in Africa (2017) - Number of Adults (20-79) with Diabetes (in ‘000s), Diabetes age-adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed diabetes (20-79) ('000s), and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart)

Table 142. Diabetes and Population Statistics in Middle East and North Africa for 2017 and 2045 (includes corresponding Graph/Chart)

Table 143. Diabetes Statistics in Middle East and North Africa (2017) - Number of Adults with Diabetes (in 000s), Diabetes age-adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed diabetes (20-79) ('000s), and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart)

Key Opportunity Indicator: Aging Population

Table 144. Aging Population in the Middle East by Country (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)

Table 145. Aging Population in Africa by Region (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)

B. Market Analytics

Table 146. Rest of World Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 147. Rest of World Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 148. Rest of World 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

8. COMPANY PROFILES

Total Companies Profiled: 58 (including Divisions/Subsidiaries - 75)
The United States (35)
Canada (1)
Japan (4)
Europe (23)
  France (2)
  Germany (4)
  The United Kingdom (8)
  Italy (1)
  Rest of Europe (8)
Asia-Pacific (Excluding Japan) (10)
Middle East (2)